Friday 8 de May 2020
17.00 h.

How will health care be organized post-COVID?

The current COVID-19 crisis poses a huge challenge to society and the health system, and its professionals in particular. Beyond the response offered to acute cases in this first wave, there is great concern about what may happen in the short, medium, and long term. We are faced with various scenarios for which we do not currently have a helpful guide for operation. We lack evidence, yet we can point to some challenges that will force us to offer concrete solutions.

The first has been concerned with the large number of professionals infected by the virus, unparalleled in any other country. And also to the fears that the infection itself generates in the population when dealing with the health system. However, it is necessary to keep in mind the following waves of patients coming: urgent non-COVID-19 patients delayed by resource constraints, chronic patients not adequately followed up with during the crisis, or the socio-economic effects of the pandemic itself on the population.

Therefore, we are at a crossroads where, on the one hand, we are going to have a high and sustained demand for care, and on the other, we are going to be unable to maintain the same organization of care that we have enjoyed up until now. Nevertheless, opportunities for improvement appear, and Technology will likely offer us a good number of solutions. It seems that the time has come to implement eHealth decisively: for example, extensive use of telemedicine and home medicine dispensing, taking advantage of information systems to predict events and prioritize and anticipate resources, monitoring health status using smartphones, or adjusting medical visits to the real needs of the patient, rather than a pre-set schedule. And interesting challenges appear, such as distance learning and the future of congresses, as well as the relationship between the pharmaceutical industry and professionals.

To reflect on all these points, we have an excellent panel of opinion leaders, with diverse areas of expertise. Gerardo CajaravilleHead of Pharmacy at Onkologikoa Fundazioa Hospital in GuipúzcoaAngel Luis GuerreroNeurologist, Headache Unit Coordinator and Headache Research Group at Hospital Universitario Valladolid;Maria Victoria MateosHaematologist at the Haematology Department of the Complejo Asistencial Universitario de Salamanca and Instituto Biosanitarío de Salamanca (CAUSA/IBSAL); and Fernando RiveraHead of the Medical Oncology Service of the Hospital Universitario Marqués Valdecilla (Santander), together with the participation of Luis Lizándirector of Outcomes’10.

Webinars speakers

Dr. Gerardo Cajaraville
Head of Hospital Pharmacy
Onkologikoa Foundation of Donosti

Dr. Gerardo Cajaraville is currently Head of the Pharmacy Service, Director of Quality and Information Systems, and Patient Safety leader at the Onkologikoa Foundation in San Sebastian.

He has dedicated almost his entire professional career to Oncology Pharmacy, and he is the founder of the Spanish Group for the development of Oncology Pharmacy (Gedefo) in 2002. He has also received the Joaquín Bonal medal awarded by the Spanish Society of Hospital Pharmacy in 2014.

In recent years, he has been mainly dedicated to Innovation as the principal researcher in various R+D+i projects, such as applying technologies for patient safety and clinical traceability, robotic preparation of chemotherapy, and measurement of results in oncology.

For some time now, he has been involved in various projects trying to adapt information systems to obtain health outcomes and, therefore, to determine the actual value of clinical practice.

Dr. Ángel Luis Guerrero
Headache Unit Coordinator
Valladolid Clinical Hospital

Doctor of Medicine from the Universidad de Valladolid and specialist in Neurology.

Since 2007, Dr. Ángel Luis Guerrero has been working in the Neurology Department of the Hospital Clínico Universitario de Valladolid and is an associate professor in the Faculty of Medicine. In addition, he is responsible for the Headache Unit of the Hospital Clínico, which has been active since January 2008 and is recognized as a leading unit in the region.

He has been awarded the S.E.N. Cephalea Award by the Spanish Society of Neurology (S.E.N.) on two occasions. The S.E.N. Awards represent recognition by the Spanish Society of Neurology and Spanish neurologists of health professionals who have contributed to the development of this specialty, the knowledge of neurological diseases, and the social awareness of patients suffering from them.

He has co-authored more than 150 articles and book chapters and more than 200 communications in national and international congresses.

Dra. Maria Victoria Mateos
Hematology Service
University Clinical Hospital of Salamanca

Dr. Mariví Mateos is Director of the Myeloma Unit at the Hospital Universitario de Salamanca, responsible for coordinating the Haematology Clinical Trials Unit, and is an associate professor of hematology.

She is also a member of the European Association of Haematology. Last year, the International Myeloma Foundation (I.M.F.) recognized Dr. Mateos for significantly improving the lives of multiple myeloma patients with the Brian Durie award – the Outstanding Achievement Award 2019. She also received the Multiple Myeloma Excellence Award in Paris last year.

Among the achievements that have earned her these awards are: treatment optimization, early treatment of asymptomatic myeloma, evaluation of minimal residual disease, innovative research, and his contribution to progress in the field of multiple myeloma.

She has also been recognized for having one of the best curricula in terms of impact rates of the publications generated during the last four years.

Dr. Fernando Rivera
Head of Medical Oncology
Marqués de Valdecilla University Hospital

Currently, Dr. Fernando Rivera is Head of the Department of Medical Oncology at the Hospital Universitario Marqués de Valdecilla in Santander and Manager of the Clinical Trials Unit in the same department. He graduated in Medicine from the Universidad de Salamanca in 1988 and received his doctorate from the Universidad de Cantabria in 2006.

He is also a member of the Spanish Society of Medical Oncology.

Regarding the publications developed by Dr. Rivera, he is the author of 16 scientific articles published in national journals and 125 international publications.

He has co-authored 23 books and edited one of them.

He is passionate about history and advocates for incorporating artificial intelligence to help characterize tumors and plan treatments.

luis lizan
Luis Lizán

Outcomes'10 is a scientific and strategic consultancy specializing in Health Outcomes Research, Health Economics, and Market Access, collaborating with the Pharmaceutical Industry, Health Technology Industry, Health Professionals, Scientific Societies, Patient Associations, Business Schools, and Universities to develop innovative projects.

We are a multidisciplinary team of more than twenty professionals located in the excellent environment offered by the Science, Business, and Technology Park of Universidad Jaime I, which allows us to maintain a dynamic, agile and collaborative relationship with other working groups in the area of health and new technologies applied to management and research.

Skip to content